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Abstract
A dengue nonstructural protein 1 (NS1) antigen capture enzyme-linked immunosorbent assay (ELISA)-based tissue culture
infectious dose-50 (TCID50) test (TCID50-ELISA) was developed as an alternative to the standard plaque assay for titrating
dengue virus. Virus titers obtained by TCID50-ELISA were comparable to those obtained by the plaque assay and by the
traditional TCID50-cytopathic effect (CPE) test (TCID50-CPE), with a better reproducibility and a lower coefficient of variation.
Quantitative comparison of TCID50-ELISA and TCID50-CPE resulted in a correlation coefficient of 0.976. Moreover, this new
method showed a wider application to C6/36, Vero E6, BHK-21, and Vero cells compared with other titration methods. In
summary, the novel TCID50-ELISA method described here provides a more reliable and more accurate alternative compared
to the plaque assay and TCID50-CPE for titration of dengue virus.
Citation: Li J, Hu D-m, Ding X-x, Chen Y, Pan Y-x, et al. (2011) Enzyme-Linked Immunosorbent Assay-Format Tissue Culture Infectious Dose-50 Test for Titrating
Dengue Virus. PLoS ONE 6(7): e22553. doi:10.1371/journal.pone.0022553
Editor: Pedro Lagerblad Oliveira, Universidade Federal do Rio de Janeiro, Brazil
Received March 11, 2011; Accepted June 24, 2011; Published July 25, 2011
Copyright:  2011 Li et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grant 30725031 from the National Outstanding Young Scientist Foundation of China, grant 2009ZX10004-306 of the
National Science and Technology Major Project of China, and grant 30671874 of the Research Program of the National Natural Science Foundation of China. The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: chexiaoyan@126.com
Introduction
Over the past 60 years, dengue fever and dengue haemorrhagic
fever have become increasingly serious public health problems in
the tropics and subtropics due to overpopulation, ever-increasing
regional and international travel, as well as global warming [1].
Dengue virus (DENV), a member of the family Flaviviridae, genus
Flavivirus, is an enveloped, single-stranded RNA virus comprising
four antigenically distinct serotypes: DENV1, DENV2, DENV3,
and DENV4. Infection with any one of the four serotypes can
result in a broad spectrum of consequences, including asymptom-
atic infection, mild febrile illness, classic dengue fever, and the
lethal dengue haemorrhagic fever (DHF)/dengue shock syndrome
(DSS) [2]. Research on DENV is often hindered by inefficient and
inaccurate or costly viral titration methods [3]. Hence, a simple
and efficient assay for accurate titration of DENV in infected
cultures would greatly facilitate dengue research, vaccine devel-
opment, and laboratory detection. To date, a variety of methods
for titrating DENV have been developed, including classical
assays, the plaque assay and the tissue culture infectious dose-50
assay (TCID50), and immunofluorescence-based assays such as
fluorescence-activated cell sorting (FACS) assay and fluorescent
focus assay [4,5,6,7]. As a standard method for titrating DENV,
however, the plaque or TCID50 assays have their disadvantages, as
they are limited to some strains and passages of the virus, and a
few cell lines [5]. Most primary clinical isolates do not form
clear plaques or have a visible cytopathic effect (CPE) on cell
monolayers. Furthermore, both of these assays require manual
microscope examination daily, which is time consuming and
labour intensive. FACS and fluorescent focus assays can pro-
vide more rapid and accurate quantitation of DENV than the
traditional plaque assay [4,6]. However, each of these techniques
requires experienced technicians and sophisticated laboratories,
hindering its application in most laboratories lacking sophisticated
equipment. Therefore, convenient methods for titrating the virus
need to be developed. Nonstructural protein 1 (NS1), a multi-
functional glycoprotein in dengue virus, is highly conserved for all
serotypes of DENV and is strongly immunogenic [8]. Some of the
NS1 protein is expressed as a soluble secreted form, which has
been implicated to contribute to dengue viral propagation and the
amount secreted is closely related to dengue viral titer [9]. In our
previous study, we established a dengue NS1 antigen capture
enzyme-linked immunosorbent assay (ELISA) [10]. In the present
study, a novel TCID50 assay was developed, which employs this
dengue NS1 antigen capture ELISA for the accurate and objective
titration of DENV.
Materials and Methods
Cells and viruses
Aedes albopictus cells (C6/36, ATCC:CRL-1660) were main-
tained in minimum essential medium (MEM; Gibco) supplement-
ed with 10% fetal bovine serum (FBS; HyClone Laboratories,
Logan, Utah) and 0.1% gentamicin (50 mg/mL, Sigma Chemical
Co., St. Louis, Mo.) at 28uCo r3 7 uCi n5 %C O 2. African green
monkey kidney cells (Vero E6, ATCC:CRL-1586), Hamster
kidney cells (BHK-21, ATCC:CCL-10) and African green monkey
kidney cells (Vero, ATCC:CCL-81) were maintained in MEM
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mL) at 33uCi n5 %C O 2.
DENV serotypes used in TCID50-CPE, TCID50-ELISA and
plaque assay were as follows: DENV1, Hawaii; DENV2, New
Guinea-C; DENV3, Guanxi-80-2; DENV4, H241. The four
serotypes of DENV were obtained from the Center for Disease
Control and Prevention of Guangzhou, China. The virus working
stocks were prepared by growing in C6/36 cells at 33uCi n5 %
CO2 for 3 to 5 days. After the cytopathic effect (CPE) was
observed, cell culture supernatant was collected, clarified by
centrifugation, supplemented with 20% heat-inactivated FBS, and
stored in aliquots at 280uC.
Plaque assay in Vero E6 cells
The plaque assay in Vero E6 cells was performed using a
protocol modified from Roehrig [11]. Briefly, Vero E6 cells were
seeded in six-well plates at a density of 4610
5 cells/well and
incubated overnight at 33uCi n5 %C O 2 until cells were ap-
proximately 80% to 90% confluent. Medium was removed from
cells, and replaced with 500 ml of medium (MEM with 2% FBS)
containing 10-fold serial dilutions of virus. Viral adsorption was
allowed to proceed for 90 min at 33uC with rocking of the plates
every 15 min. The supernatant was aspirated off gently and the
monolayers were overlaid with 3 mL per well of MEM containing
2% FBS, 1.2% carboxymethyl cellulose (Sigma) and 0.1%
gentamicin (50 mg/mL). Plates were incubated at 33uCi n5 %
CO2 for 5 to 7 days or until the CPE was observed. Next, the
nutrient agar overlay was removed and the cells were fixed with
4% formalin for 1 hour. Staining solution (1 mL per well)
containing 0.8% crystal violet (Sigma) was added then removed
after 15 min. Plates were rinsed and dried at room temperature,
and plaques were counted immediately. The assay was carried out
in triplicate and the plaque counts were averaged. The viral titers
were expressed as plaque-forming units (PFU)/mL, calculated as
[(number of plaques per well)6(dilution)]/(inoculum volume).
TCID50-CPE
TCID50-CPE was performed using a protocol modified from
Schoepp and Beaty [12]. Briefly, cells were seeded in a 96-well
plate at a density of 2.5610
5 cells/well (C6/36 cells) or 1610
4
cells/well (Vero E6, BHK-21 or Vero cells) in 200 mL and
incubated overnight at 28uC (37uC for mammalian cells) in 5%
CO2. Ten-fold serial dilutions of the virus were prepared in MEM
(10
21–10
210) and 100 mL of each dilution was added to 10 seeded
wells. Viral adsorption was allowed to proceed for 90 min at 33uC.
The supernatant was aspirated off gently and the monolayers were
overlaid with 200 mL per well of MEM with 0.1% gentamicin.
Ten negative control wells without virus were included in each
plate, and the CPE was observed daily using an inverted
microscope. The 50% tissue culture infectious dose (TCID50)o f
each virus was calculated as described by Reed and Muench
(1938) when no further CPE was observed [13].
TCID50-ELISA
C6/36, Vero E6, Vero, or BHK-21 cells were seeded in 96-well
plates at an appropriate density. The TCID50-CPE assay was
performed to titrate DENV1 to 4 as described above. After an
appropriate incubation period, the NS1 protein in 100 mLo f
culture supernatant from each well was determined using a dengue
NS1 antigen capture ELISA method established previously in our
laboratory [10]. The optical densities (ODs) were read at 450 nm
using SureBlue Reserve
TM TMB Microwell Peroxidase Substrate
(KPL) containing 3,39,5,59 tetramethylbenzidine in a mildly acidic
buffer for color development. The cutoff value was established as
the 2.1-fold of the mean OD value of control cells without virus.
The CPE of each microtiter plate was read by two investigators
independently just before the ELISA test. The final titer of
TCID50-CPE was defined as the mean value of the titers obtained
by both investigators, and the results of TCID50-CPE read by each
investigator were compared with the corresponding results of
TCID50-ELISA.
Determination of incubation time for TCID50-ELISA
To determine the optimal incubation time for titrating DENV 1
to 4 using TCID50-ELISA, we conducted the TCID50-CPE test in
C6/36 and Vero E6 cells as described above. The plates were
incubated for 2, 4, 6, 8, 10, 15, or 20 days. After incubation,
TCID50-ELISA was performed to determine the NS1 protein in
Table 1. Titration of DENV 1 to 4 by TCID50-ELISA and TCID50-
CPE in Vero E6 and C6/36 cells, at seven different incubation
times.
Virus
Incubation
times (days) Vero E6 C6/36
ELISA
titer
a CPE titer ELISA titer CPE titer
DENV1 2 3.960.5 n/a
b 3.560.0 n/a
45 . 5 60.9 4.561.0 6.160.2 2.560.0
66 . 0 60.4 5.960.5 6.560.2 n/a
86 . 3 60.4 5.960.4 6.460.0 n/a
10 6.560.2 6.160.5 6.460.2 n/a
15 6.360.2 6.160.3 6.560.2 n/a
20 6.560.4 6.360.5 6.660.1 n/a
DENV2 2 3.560.0 n/a 4.560.0 n/a
44 . 6 60.0 4.660.1 7.060.1 5.260.6
65 . 9 60.3 5.760.4 7.060.3 n/a
85 . 9 60.3 5.660.4 7.060.2 n/a
10 6.060.4 5.560.4 7.060.1 n/a
15 5.760.2 5.560.5 7.060.2 n/a
20 5.960.2 5.660.3 6.860.1 n/a
DENV3 2 2.960.3 n/a 2.660.1 n/a
44 . 6 60.1 3.561.0 5.760.1 n/a
65 . 2 60.2 4.560.1 6.460.4 4.761.0
85 . 4 60.1 4.660.2 6.260.5 5.460.1
10 5.560.1 4.760.3 6.360.4 6.060.2
15 5.260.3 4.860.3 6.360.1 6.160.2
20 5.560.3 5.160.3 6.360.1 6.460.1
DENV4 2 3.260.6 n/a 2.460.2 n/a
44 . 7 60.4 4.860.6 5.760.3 n/a
65 . 7 60.1 5.760.1 6.460.6 5.360.8
85 . 7 60.2 5.660.1 6.360.4 5.561.0
10 5.860.2 5.760.2 6.260.4 5.460.9
15 5.760.1 5.660.1 6.260.2 6.060.4
20 5.560.1 5.560.1 6.360.5 6.260.4
aGeometric mean titer (titers are expressed as log10TCID50 per milliliter). Each
number represents the mean of three tests 6 standard deviation.
bn/a=not applicable. CPE did not develop or could not be distinguished from
control cells.
doi:10.1371/journal.pone.0022553.t001
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Data analysis
All statistical analyses were performed using statistical package
version SPSS 13.0. Kruskal-Wallis test, Friedman’s test and
Wilcoxon’s signed rank test were used to evaluate the statistical
significance of the results. A P value,0.05 was considered
statistically significant for all parameters.
Results
Determination of incubation time for TCID50-ELISA assay
TCID50-ELISA assays were conducted with C6/36 and Vero
E6 cell lines for optimization of the incubation time (Table 1).
After incubation for 2, 4, 6, 8, 10, 15, or 20 days, significant
differences between the TCID50-ELISA titers of DENV 1 to 4
were observed (Kruskal-Wallis test, P=0.000). However, as shown
in Figure 1, the TCID50-ELISA titers increased significantly up
to day 6 and then remained stable up to day 20. Additionally, the
mean rank value of TCID50-ELISA titers obtained by day 6 was
very similar to the results obtained over the next 4 time points
(Kruskal-Wallis test). Hence, the 6 day incubation appeared to be
sufficient for the infected cells to produce enough NS1 protein to
be detected by ELISA, and this assay should be applicable to
cultures at anytime between 6 and 20 days.
Qualitative and quantitative comparisons of TCID50-
ELISA, TCID50-CPE and plaque assay
Accuracy. The accuracy of the TCID50-ELISA assay was
evaluated by comparing the titers from TCID50-ELISA with those
from TCID50-CPE, which is one of the classic methods for DENV
titration. Serial 10-fold dilutions of DENV were inoculated into
four susceptible cell lines (C6/36, Vero E6, Vero, and BHK-21),
TCID50 assays were performed, and CPE was observed and
recorded daily. Although 6 days of incubation is enough for the
TCID50-ELISA as described above, 10 days was chosen for these
TCID50 assays because CPE in Vero or BHK-21 cells was not
observed at earlier time points (data not shown). After 10 days of
incubation, 100 mL of supernatant from each well was aspirated
and assayed for the NS1 antigen using our ELISA method. No
significant differences were observed between the titers of DENV
obtained by TCID50-ELISA and by TCID50-CPE in C6/36
(Friedman test, P=0.068), Vero E6 (P=0.465), Vero (P=0.068),
or BHK-21 cells (P=0.273). Moreover, the titers of DENV
obtained by TCID50-ELISA or TCID50-CPE in different cells
were significantly different (Friedman test; P=0.026 and
P=0.011, respectively). A good agreement was observed
between the titers from TCID50-CPE and TCID50-ELISA, with
a correlation coefficient of 0.976 (R
2=0.955, P=0.000, Figure 2).
It was noted that the TCID50-CPE titers sometimes could not be
obtained accurately because of nonspecific changes in cell cultures
due to non-optimal growth medium or cell aging. These results
demonstrate high accuracy and reliability of the TCID50-ELISA
assay, and also showed that it has a wider application than
TCID50-CPE because the results appeared to be unaffected by the
state of cell line used.
Reproducibility. Reproducibility of the TCID50-ELISA
assay was evaluated in several ways. First, the titers of DENV
obtained by TCID50-ELISA, TCID50-CPE and plaque assay were
analyzed, and their coefficients of variation (CVs) were compared.
The titers of the TCID50-ELISA assay exhibited the smallest CV
Figure 1. Determination of the incubation time for titration of DENV 1 to 4 by TCID50-ELISA. Supernatants for TCID50 tests from Vero E6
cells (A) and C6/36 cells (B), which had been exposed to DENV1 to 4 for 2, 4, 6, 8, 10, 15, 20 days, were collected and analyzed for NS1 production by
ELISA. Data are averaged from 3 separate experiments. Results are shown as means 6 standard deviations.
doi:10.1371/journal.pone.0022553.g001
Figure 2. Correlation between virus titers obtained by TCID50-
CPE and TCID50-ELISA of DENV1 to 4. R
2=0.955. Data are from 12
separate titrations with each virus titered three times.
doi:10.1371/journal.pone.0022553.g002
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0.099). The plaque assay had the highest CV (CV=0.272). When
the same dilutions of DENV were inoculated in C6/36, Vero E6,
Vero, or BHK-21 cells in a parallel plaque assay, suitable plaques
developed in Vero E6 cells but not in other three cell lines. Thus,
the plaque assay is applicable only to particular cell lines.
Comparison of the CVs from the four cell lines showed no
significant differences between the results obtained from TCID50-
ELISA and TCID50-CPE (Wilcoxon signed ranks test). In
addition, there were no significant differences between the CVs
from the four cell lines when tested by TCID50-ELISA or by
TCID50-CPE (Friedman test; P=0.825 and P=0.552,
respectively). All these results showed that the TCID50-ELISA
assay has a higher degree of reproducibility and is applicable to a
wider range of cell lines than the plaque assay and the TCID50-
CPE assay.
Discussion
Dengue viruses are spherical, lipid-enveloped viruses that
contain a positive strand RNA genome of approximately 10,200
nucleotides coding for three structural proteins (capsid, mem-
brane, and envelope) and seven nonstructural proteins (NS1,
NS2a, NS2b, NS3, NS4a, NS4b, NS5) [14]. NS1, as a key marker
of ongoing dengue viral replication, is secreted into the extra-
cellular fluid and is also expressed on the surface of infected cells
[15]. A novel TCID50 assay is described for determination of
dengue virus titers, which relies on detecting the DENV NS1
protein by ELISA. In this TCID50-ELISA assay, the observation
of the CPE was replaced by determination of NS1 protein, which
can eliminate subjective variations between operators and labo-
ratories. With this method, we were able to run large numbers of
titration tests and to automate reading and recording of the data.
This novel TCID50-ELISA method has several advantages over
the plaque assay and the TCID50-CPE assay. A major advantage
of the TCID50-ELISA assay is the ability to quantitate viruses
using cell lines in which a CPE is not detectable or plaques are not
visible. This widens the range of cell lines in which viral titer can
be detected. For instance, viral titers were obtained for DENV 1 to
4 in BHK-21 and Vero cells, in which a CPE was not observed.
Moreover, the results of the TCID50-ELISA assay described here
can be recorded automatically from the plate in which the test is
carried out. This simplifies the test procedure and eliminates the
fatigue and subjectivity associated with reading large numbers of
tests in the CPE analysis. Furthermore, the TCID50-ELISA assay
showed better reliability because the ELISA results are not subject
to nonspecific changes in cells, which can make CPE reading
difficult. Finally, the TCID50-ELISA assay has been used
successfully for clinically DENV isolates, which might not be
assessable by other titration methods (data not shown). In
conclusion, an efficient assay for titration of DENV is reported.
The method was validated by comparison with data obtained by
other techniques. This TCID50-ELISA assay overcomes the flaws
inherent in the plaque assay and the TCID50-CPE assay. Based on
its reliability and ease of execution, the TCID50-ELISA test
represents a promising assay for titration of DENV, and will
facilitate dengue research.
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